We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$356M
AUM Growth
+$21.4M
Cap. Flow
+$13.5M
Cap. Flow %
3.78%
Top 10 Hldgs %
21.9%
Holding
167
New
14
Increased
82
Reduced
36
Closed
17

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$6.43M
2
SLB icon
SLB Ltd
SLB
+$3.78M
3
PETM
PETSMART INC
PETM
+$3.64M
4
TSM icon
TSMC
TSM
+$3.11M
5
TM icon
Toyota
TM
+$2.51M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.53M
2
KDP icon
Keurig Dr Pepper
KDP
+$4.88M
3
FFIV icon
F5
FFIV
+$3.47M
4
CA
CA, Inc.
CA
+$2.97M
5
MDT icon
Medtronic
MDT
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 12.43%
3 Industrials 12.11%
4 Energy 9.92%
5 Financials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.35T
$9.06M 2.54%
220,992
+5,914
+3% +$222K
AAPL icon
2
Apple
AAPL
$4.9T
$8.71M 2.45%
454,636
+6,020
+1% +$115K
INTC icon
3
Intel
INTC
$460B
$8.34M 2.34%
322,927
+7,925
+3% +$198K
CSX icon
4
CSX Corp
CSX
$93B
$7.67M 2.15%
793,833
+14,658
+2% +$136K
LYB icon
5
LyondellBasell Industries
LYB
$19.5B
$7.65M 2.15%
86,002
+2,903
+3% +$244K
XLNX
6
DELISTED
Xilinx Inc
XLNX
$7.59M 2.13%
139,939
+2,432
+2% +$121K
CSCO icon
7
Cisco
CSCO
$448B
$7.3M 2.05%
325,495
+13,902
+4% +$307K
NVS icon
8
Novartis
NVS
$301B
$7.26M 2.04%
95,273
+3,441
+4% +$251K
ORCL icon
9
Oracle
ORCL
$367B
$7.23M 2.03%
176,648
+2,684
+2% +$102K
NVO
10
Novo Nordisk
NVO
$228B
$7.17M 2.01%
313,960
-500
-0.2% -$10.7K
MCD icon
11
McDonald's
MCD
$191B
$7.08M 1.99%
72,240
+4,701
+7% +$450K
ACN icon
12
Accenture
ACN
$99.9B
$7.06M 1.98%
88,529
+2,787
+3% +$229K
EMC
13
DELISTED
EMC CORPORATION
EMC
$6.89M 1.93%
251,248
+3,503
+1% +$91.1K
UNP icon
14
Union Pacific
UNP
$172B
$6.76M 1.9%
72,030
+4,376
+6% +$389K
OXY icon
15
Occidental Petroleum
OXY
$55.6B
$6.74M 1.89%
73,832
+3,299
+5% +$295K
BLK icon
16
Blackrock
BLK
$170B
$6.59M 1.85%
20,966
+557
+3% +$170K
XOM icon
17
ExxonMobil
XOM
$651B
$6.54M 1.84%
66,906
+3,570
+6% +$340K
JWN
18
DELISTED
Nordstrom
JWN
$6.43M 1.81%
103,013
+8,555
+9% +$515K
TROW icon
19
T. Rowe Price
TROW
$25.6B
$6.38M 1.79%
77,422
+4,125
+6% +$334K
GEN icon
20
Gen Digital
GEN
$16.3B
$6M 1.68%
+300,398
New +$6.43M
QCOM icon
21
Qualcomm
QCOM
$160B
$5.93M 1.66%
75,166
+928
+1% +$69.9K
TGT icon
22
Target
TGT
$65.6B
$5.75M 1.62%
95,040
+6,038
+7% +$358K
TPR icon
23
Tapestry
TPR
$30.8B
$5.69M 1.6%
114,520
+7,783
+7% +$387K
SSL icon
24
Sasol
SSL
$7.51B
$5.58M 1.57%
99,880
+6,615
+7% +$334K
WU icon
25
Western Union
WU
$2.4B
$5.39M 1.51%
329,379
+15,209
+5% +$248K
1
2 3 4 5

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return

Grimes & Company's Q1 2014 Portfolio in Review

As of Q1 2014, Grimes & Company held 167 positions worth $356M, up 6.4% from $335M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Grimes & Company deployed $13.5M of net new capital in Q1 2014, opening 14 new positions and adding to 82 existing holdings. Its largest new stake was Gen Digital: 300,398 shares worth $6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AstraZeneca, an estimated $6.53M trimmed.

  • Grimes & Company's largest Q1 2014 buy was Gen Digital: 300,398 shares worth $6M.
  • Grimes & Company added most to SLB Ltd in Q1 2014, an estimated $3.78M increase.
  • Grimes & Company's biggest Q1 2014 reduction was AstraZeneca, cutting an estimated $6.53M.
  • Grimes & Company fully exited F5 in Q1 2014, selling an estimated $3.47M.
  • Grimes & Company's ten largest holdings make up 22% of its $356M portfolio in Q1 2014.
  • Grimes & Company opened 14 new positions and closed 17 in Q1 2014.
  • Grimes & Company's portfolio value rose 6.4% quarter-over-quarter to $356M.

Based on Grimes & Company's 13F filing for Q1 2014, filed 1 May 2014.